PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

Verndari, Inc. Announces Funding from U.S. Government Agency BARDA to Accelerate Development of VaxiPatch™ Dermal Patch Vaccine Technology

NAPA, Calif.--(BUSINESS WIRE)-- #COVID19--Verndari, Inc., a biopharmaceutical company transforming vaccines with...

COVID-19 Vax: Dont Cut Corners on Safety and Efficacy, says AHF

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the largest global AIDS organization, calls...

 VBI Vaccines Announces Preclinical Coronavirus Program Data and Selection of Clinical Candidates with Potential as One-Dose Vaccines

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage...

TYME’s Oncology Research Reveals Potential New Oral Therapy TYME-19 in the Fight Against COVID-19

BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology...

QIAGEN to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies Following FDA Emergency Use Authorization

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime...

Recent Articles